1. Amelioration of Ethanol-Induced Hepatitis by Magnesium Isoglycyrrhizinate through Inhibition of Neutrophil Cell Infiltration and Oxidative Damage
   Yan Wang et al, 2017, Mediators of Inflammation CrossRef
2. Comparative effectiveness of glycyrrhizic acid preparations aimed at improving liver function of patients with chronic hepatitis B: A network meta-analysis of 53 randomized controlled trials
   Wen Gao et al, 2023, Phytomedicine CrossRef
3. Glycyrrhizin and the Related Preparations: An Inspiring Resource for the Treatment of Liver Diseases
   Yu Mou et al, 2024, The American Journal of Chinese Medicine CrossRef
4. Effects of magnesium isoglycyrrhizinate on AST, ALT, and serum levels of Th1 cytokines in patients with allo-HSCT
   Jinglong Lv et al, 2017, International Immunopharmacology CrossRef
5. Magnesium isoglycyrrhizinate has hepatoprotective effects in an oxaliplatin‑induced model of liver injury
   Xueqing Zou et al, 2018, International Journal of Molecular Medicine CrossRef
6. Morphological changes in the rat’s liver of different age after administration of magnesium chloride
   Roman V. Yanko et al, 2019, Journal of the Belarusian State University. Biology CrossRef
7. Small Molecule Regulators of Ferroptosis
   Sylvain Debieu et al, 2021, Ferroptosis: Mechanism and Diseases CrossRef
8. Inhibition of myocardial hypertrophy by magnesium isoglycyrrhizinate through the TLR4/NF-κB signaling pathway in mice
   Donglai Ma et al, 2018, International Immunopharmacology CrossRef
9. Magnesium isoglycyrrhizinate prevents cadmium-induced activation of JNK and apoptotic hepatocyte death by reversing ROS-inactivated PP2A
   Xiaoling Chen et al, 2021, Journal of Pharmacy and Pharmacology CrossRef
10. Magnesium isoglycyrrhizinate ameliorates lipopolysaccharide-induced liver injury by upregulating autophagy and inhibiting inflammation via IL-22 expression
    Xu Zhou et al, 2022, Bioorganic Chemistry CrossRef
11. Magnesium Isoglycyrrhizinate Ameliorates Fibrosis and Disrupts TGF-β-Mediated SMAD Pathway in Activated Hepatic Stellate Cell Line LX2
    Jie Kai Tee et al, 2018, Frontiers in Pharmacology CrossRef
12. An overview of ferroptosis in non-alcoholic fatty liver disease
    Shendong Wang et al, 2022, Biomedicine & Pharmacotherapy CrossRef
13. Serum magnesium concentration is independently associated with non-alcoholic fatty liver and non-alcoholic steatohepatitis
    Ahad Eshraghian et al, 2018, United European Gastroenterology Journal CrossRef
14. Protective Effects of Magnesium Glycyrrhizinate on Methotrexate-Induced Hepatotoxicity and Intestinal Toxicity May Be by Reducing COX-2
    Yuzhu Cao et al, 2019, Frontiers in Pharmacology CrossRef
15. Association of Hypomagnesemia and Liver Injury, Role of Gut-Barrier Dysfunction and Inflammation: Efficacy of Abstinence, and 2-Week Medical Management in Alcohol Use Disorder Patients
    Evan J. Winrich et al, 2022, International Journal of Molecular Sciences CrossRef
16. Modulation of Gut Microbiota by Magnesium Isoglycyrrhizinate Mediates Enhancement of Intestinal Barrier Function and Amelioration of Methotrexate-Induced Liver Injury
    Yawen Xia et al, 2022, Frontiers in Immunology CrossRef
17. Magnesium isoglycyrrhizinate blocks fructose-induced hepatic NF-κB/NLRP3 inflammasome activation and lipid metabolism disorder
    Xiao-Juan Zhao et al, 2017, European Journal of Pharmacology CrossRef
18. Mangiferin ameliorates fatty liver via modulation of autophagy and inflammation in high-fat-diet induced mice
    Hu Wang et al, 2017, Biomedicine & Pharmacotherapy CrossRef
19. Magnesium Isoglycyrrhizinate Reduces Hepatic Lipotoxicity through Regulating Metabolic Abnormalities
    Li Lu et al, 2021, International Journal of Molecular Sciences CrossRef
20. Magnesium isoglycyrrhizinate attenuates acute alcohol-induced hepatic steatosis in a zebrafish model by regulating lipid metabolism and ER stress
    Wencong Dai et al, 2022, Nutrition & Metabolism CrossRef
21. Magnesium Isoglycyrrhizinate attenuates lipopolysaccharide-induced depressive-like behavior in mice
    Wenjiao Jiang et al, 2017, Biomedicine & Pharmacotherapy CrossRef
22. Magnesium isoglycyrrhizinate alleviates fructose-induced liver oxidative stress and inflammatory injury through suppressing NOXs
    Yan-Zi Yang et al, 2020, European Journal of Pharmacology CrossRef